Literature DB >> 21882202

Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.

Woo Seok Kim1, Dong Wook Choi, Seoung Ho Choi, Jin Seok Heo, Dong Do You, Hyung Geun Lee.   

Abstract

BACKGROUND: Ampullary cancer is considered to have a better prognosis than cancers of the distal bile duct and pancreas, and recent publications emphasize the prognostic importance of the histologic differentiation of the intestinal and pancreatobiliary types of ampullary cancer. The aims of this study were to identify those factors that affect recurrence after curative resection and to investigate differences between the clinicopathologic features of these two pathologic subtypes. PATIENTS AND METHODS: The medical records of patients that underwent pancreatoduodenectomy for ampullary carcinoma from February 1995 to March 2009 at our institute were retrospectively reviewed. One hundred and four patients that underwent curative resection for ampullary carcinoma were enrolled in this study. One pathologist reviewed all pathologic reports and histopathologic findings. Data on clinicopathologic factors and disease free and overall survival were analyzed.
RESULTS: The 3- and 5-year disease free survival rates of the 104 study subjects were 62.2% and 57.7%, respectively, and overall survival rates were 69.4% and 60.1%, respectively. Multivariate analysis showed that an advanced T stage (P = 0.049), the presence of lymph node metastasis (P = 0.003), poor differentiation (P = 0.039), and the pancreatobiliary type (P = 0.022) significantly increased the risk of recurrence. Furthermore, the pancreatobiliary type was found to be more associated with an advanced T stage (P = 0.009), regional lymph node metastasis (P = 0.007), and perineural invasion (P = 0.026) than the intestinal type. In addition, pathologic subtype analysis showed that Carcinoembryonic antigen (CEA) level and lymph node metastasis were important predictors of recurrence in patients with the intestinal (P = 0.013) and pancreatobiliary types, respectively (P = 0.003).
CONCLUSIONS: An advanced T stage, nodal metastasis, poor differentiation, and the pancreaticobiliary type were found to be independent predictors of recurrence after curative resection of ampullary carcinoma by multivariate analysis. In addition, the pancreatobiliary type tended to present in a more advanced T stage and more frequently with regional lymph node involvement and perineural invasion than the intestinal type. Furthermore, CEA level and lymph node metastasis were found to be independent predictors of recurrence for the intestinal and pancreatobiliary types, respectively.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21882202     DOI: 10.1002/jso.22090

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  30 in total

1.  Immunohistochemical Predictors for Intestinal and Pancreatobiliary Types of Adenocarcinoma of The Ampulla of Vater.

Authors:  João Paulo Lemos da Silveira Santos; Carla Jorge Machado; Eduardo Paulino Junior; João Bernardo Sancio Rocha Rodrigues; Paula Teixeira Vidigal; Vivian Resende
Journal:  J Gastrointest Surg       Date:  2018-05-07       Impact factor: 3.452

Review 2.  Management of ampullary neoplasms: A tailored approach between endoscopy and surgery.

Authors:  Francesca Panzeri; Stefano Crippa; Paola Castelli; Francesca Aleotti; Alessandro Pucci; Stefano Partelli; Giuseppe Zamboni; Massimo Falconi
Journal:  World J Gastroenterol       Date:  2015-07-14       Impact factor: 5.742

3.  Substaging Nodal Status in Ampullary Carcinomas has Significant Prognostic Value: Proposed Revised Staging Based on an Analysis of 313 Well-Characterized Cases.

Authors:  Serdar Balci; Olca Basturk; Burcu Saka; Pelin Bagci; Lauren M Postlewait; Takuma Tajiri; Kee-Taek Jang; Nobuyuki Ohike; Grace E Kim; Alyssa Krasinskas; Hyejeong Choi; Juan M Sarmiento; David A Kooby; Bassel F El-Rayes; Jessica H Knight; Michael Goodman; Gizem Akkas; Michelle D Reid; Shishir K Maithel; Volkan Adsay
Journal:  Ann Surg Oncol       Date:  2015-03-18       Impact factor: 5.344

4.  Prognostic Value of Preoperative Serum Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 After Resection of Ampullary Cancer.

Authors:  Tobias S Schiergens; Bernhard W Renz; Simone Reu; Jens Neumann; Rami Al-Sayegh; Hanno Nieß; Matthias Ilmer; Stephan Kruger; Stefan Boeck; Volker Heinemann; Jens Werner; Axel Kleespies
Journal:  J Gastrointest Surg       Date:  2017-09-05       Impact factor: 3.452

5.  Clinicopathologic and survival analysis of resected ampullary adenocarcinoma.

Authors:  Matthew P Doepker; Zachary J Thompson; Barbara A Centeno; Richard D Kim; Joyce Wong; Pamela J Hodul
Journal:  J Surg Oncol       Date:  2016-05-09       Impact factor: 3.454

6.  Can endoscopic papillectomy be curative for early ampullary adenocarcinoma of the ampulla of Vater?

Authors:  María-Victoria Alvarez-Sanchez; Inés Oria; Olivia B Luna; Jean Pialat; Rodica Gincul; Christine Lefort; Raphael Bourdariat; Fabien Fumex; Vincent Lepilliez; Jean Yves Scoazec; Angel Salgado-Barreira; Anne Isabelle Lemaistre; Bertrand Napoléon
Journal:  Surg Endosc       Date:  2016-08-16       Impact factor: 4.584

7.  A high positive lymph node ratio is associated with distant recurrence after surgical resection of ampullary carcinoma.

Authors:  Christina L Roland; Matthew H G Katz; Graciela M N Gonzalez; Peter W T Pisters; Jean-Nicolas Vauthey; Robert A Wolff; Christopher H Crane; Jeffrey E Lee; Jason B Fleming
Journal:  J Gastrointest Surg       Date:  2012-08-23       Impact factor: 3.452

8.  Prognostic significance of standardized uptake value on preoperative ¹⁸F-FDG PET/CT in patients with ampullary adenocarcinoma.

Authors:  Hye Jin Choi; Chang Moo Kang; Kwanhyeong Jo; Woo Jung Lee; Jae-Hoon Lee; Young Hoon Ryu; Jong Doo Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-09-13       Impact factor: 9.236

9.  Mixed adenoneuroendocrine carcinoma of the ampulla of Vater: A case report.

Authors:  Nicole Max; Alexander Rothe; Cord Langner
Journal:  Mol Clin Oncol       Date:  2016-04-14

10.  Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma.

Authors:  Shinichi Yachida; Laura D Wood; Masami Suzuki; Erina Takai; Yasushi Totoki; Mamoru Kato; Claudio Luchini; Yasuhito Arai; Hiromi Nakamura; Natsuko Hama; Asmaa Elzawahry; Fumie Hosoda; Tomoki Shirota; Nobuhiko Morimoto; Kunio Hori; Jun Funazaki; Hikaru Tanaka; Chigusa Morizane; Takuji Okusaka; Satoshi Nara; Kazuaki Shimada; Nobuyoshi Hiraoka; Hirokazu Taniguchi; Ryota Higuchi; Minoru Oshima; Keiichi Okano; Seiko Hirono; Masamichi Mizuma; Koji Arihiro; Masakazu Yamamoto; Michiaki Unno; Hiroki Yamaue; Matthew J Weiss; Christopher L Wolfgang; Toru Furukawa; Hitoshi Nakagama; Bert Vogelstein; Tohru Kiyono; Ralph H Hruban; Tatsuhiro Shibata
Journal:  Cancer Cell       Date:  2016-01-21       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.